Ilsung Is Co., Ltd. (KRX:003120)
South Korea · Delayed Price · Currency is KRW 20,350
-800 (-3.78%)
Last updated: Jan 7, 2026, 12:09 PM KST
Ilsung Is Market Cap
Ilsung Is has a market cap or net worth of 139.17 billion as of January 9, 2026. Its market cap has increased by 26.47% in one year.
Market Cap
139.17B
Enterprise Value
-83.29B
Revenue
66.51B
Ranking
n/a
PE Ratio
58.60
Stock Price
20,350.00
Market Cap Chart
Since May 22, 1998, Ilsung Is's market cap has increased from 17.63B to 139.17B, an increase of 689.60%. That is a compound annual growth rate of 7.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 139.17B | -8.39% |
| Dec 30, 2025 | 151.92B | 40.65% |
| Dec 30, 2024 | 108.02B | -34.46% |
| Dec 28, 2023 | 164.82B | 31.69% |
| Dec 29, 2022 | 125.15B | 26.20% |
| Dec 30, 2021 | 99.17B | -10.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 87.26T |
| Celltrion | 46.60T |
| ALTEOGEN | 25.59T |
| ABL Bio | 11.88T |
| SK Biopharmaceuticals | 9.77T |
| Yuhan | 8.46T |
| LigaChem Biosciences | 6.71T |
| HLB Co., Ltd. | 6.71T |